Vascular dementia (VaD) is a general term for dementia caused by organic lesions of vascular origin, which is the result of brain injury produced by cerebrovascular disease, either hemorrhagic or ischemic, or by hypoperfusive lesions resulting from cardiac disease or circulatory failure. It remains the second most common cause of dementia after Alzheimer's disease (AD), accounting for 10-50% of all cases of dementia 1,2 . However, the high prevalence of cerebrovascular and cardiovascular pathologies capable of producing VaD make it the most common form of dementia in the elderly 3 . It is reported the annual medical costs for VaD patients were substantially higher than costs for AD patients 4 .
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in polyunsaturated fatty acids which are easily oxidized. Extensive evidence supports a role for free radical generation and oxidative injury in the pathogenesis of stroke and other vascular disease 6, 7 .
Free radicals are short-lived and are difficult to measure in biological samples. However, there are some indirect indexes that can be used to examine sequela of free radical production. Urinary 8-hydroxydeoxyguanosine (8-OHdG) level has been validated as a biomarker of the rate of oxidative DNA modification 8 . The formation of 8-OHdG in DNA is an important mechanism of oxygen-radical induced mutagenesis and it is water-soluble and readily excreted in urine without further metabolism. 8-iso-prostaglandin F2a (8-isoPGF 2a ), which is produced from oxidative modification of polyunsaturated fatty acids via a free radical-catalyzed mechanism, has been suggested as a potentially useful biomarker for lipid peroxidation 9 . Furthermore, nitrotyrosine (NT) is believed to be involved in free radical chemistry reactions and appears to be an available biomarker for protein oxidation 10 .
Although oxidative stress plays a role in the brain damage seen in VaD, there is a lack of studies assessing the presence and levels of biomarkers of oxidative damage in VaD patients. Therefore, we investigated the biomarkers of oxidative stress in urine, as reflected by 8-OHdG, 8-isoPGF 2a and NT, in a group of well characterized VaD patients and in two control groups of Vascular Not Demented (VaND) patients and healthy subjects. All patients were free of any significant mental illnesses, and Hachinski Ischemia Scale scores were ≥ 7. They were included at more than two weeks after onset of VaD.
Materials and methods

Subjects
Twenty-four patients (age from 50 to 80 years) with VaND during the chronic phase were employed as controls. Cerebrovascular lesions were confirmed by neuroimaging (MRI and/or CT). The time after onset of VaND at entry to the present study ranged from three to nine months, and the MMSE scores were greater than 26.
Twenty-six persons with no signs of cognitive dysfunction were assigned to the age-matched healthy control group. They comprised individuals who visited the hospital for their annual physical check-up, had no history of circulatory disorders and showed no evident abnormalities in their electrocardiography, chest X-rays, urinalysis or blood chemistry. The MMSE scores were greater than 26. Patients receiving antioxidant vitamin therapy were excluded.
The protocol of this study was approved by the local ethics review boards, and conducted according to common standard guidelines (Declaration of Helsinki, Good Epidemiological Practice: http:// www.dundee.ac.uk/iea/GoodPract.htm).
Urine collection and assays
Urine samples were stored at −80°C immediately after collection until analysis. The urinary levels of 8-OHdG and 8-isoPGF 2a were measured by enzyme-linked immunosorbent assays (ELISA), using 8-OHdG enzyme immunoassay kit (Cayman Chemical Company, Ann Arbor, MI, USA) and 8-isoPGF 2a enzyme immunoassay kit (8-isoPGF 2a Assay Kit; Assay Designs Inc., Ann Arbor, MI, USA) respectively. Urinary NT level was measured using a chemiluminescence detection method with a nitrotyrosine assay kit (Millipore Corp., Bedford, MA, USA). Creatinine levels were analyzed to determine if differences in the biochemical parameters observed among the three groups could be attributed to group differences in the concentration of creatinine in urine. 
Statistical analysis
All statistical analysis was performed using SPSS statistical software package version 10.0 (SPSS Inc., Chicago, Illinois, USA). After testing for normal distribution, analysis of variance (ANOVA) or Kruskal-Wallis test, was used. Additional analysis of the data was performed using correlation analysis. The data were expressed as mean ± standard deviation (SD). All P values under 0.05 were considered significant.
RESULTS
The characteristics of VaD and VaND patients and healthy control subjects are detailed in Table 1 . The MMSE scores in VaD patients were significantly lower than in the other two groups. Moreover, no significant differences exsited between VaND patients and healthy control subjects. The VaD and VaND patients had significantly higher incidence of coronary artery disease and hypertension in comparison to healthy control subjects. A statistically significant inverse correlation was observed in VaD patients between MMSE and the urinary 8-OHdG (Rs=0.070, p=0.017). A statistically significant correlation was observed in VaD patients between MMSE and urinary 8-isoPGF 2a and NT levels (Rs=0.118, p= 0.001 for 8-isoPGF 2a and Rs=0.237, p=0.000 for NT).
Urinary 8-OHdG levels were significantly higher (p<0.05) in VaD patients compared with the other two groups. However, VaND patients showed no significant differences in comparison with healthy control subjects ( Table 2) .
The urinary 8-isoPGF 2a level was significantly lower in VaD patients compared to VaND patients and healthy control subjects. Whereas, no significant differences were found between VaND patients and healthy control subjects ( Table 2) .
For the NT levels, no statistically significant differences were detected among VaD patients, VaND and healthy control subjects ( Table 2) .
DISCUSSIONS
The high prevalence of VaD in aging populations emerges as a major public health problem. There is a need for prospective studies to clarify the pathogenesis of this condition and to provide appropriate measures for prevention and treatment of VaD. A lot of studies demonstrate that VaD and sroke share some common pathogenetic mechanisms including the role of oxidant stress 11 . Ryglewicz et al showed that in patients with VaD as compared with AD and healthy controls, antioxidant defense decreased and the susceptibility to oxidative stress increased 12 .
ROS-induced oxidative DNA damage is believed to contribute to neuronal cell death and neurological dysfunction. Urinary 8-OHdG level could represent the average rate of oxidative DNA damage in the whole body. It could serve as marker of oxidative stress because of its noninvasive. Plasma 8-OHdG level increased after ischemic stroke, with a significant association with brain oxidation 13 . In the present study, urinary 8-OHdG level significantly increased in VaD patients compared to VaND and healthy controls. This was consistent with other studies suggesting that dementia patients were under increased oxidative stress 14 . Plenty of evidence suggests that oxidation of DNA is affected by aging and cigarette smoking 15, 16 . In contrast, other studies indicated that neither the age nor the smoking status appear to have impact on the value of normal reference range of urinary 8-OHdG 17, 18 .
Lipid peroxidation, which refers to the oxidative degradation of lipids, is one of the major outcomes of free radical-mediated injury. Increased urinary 8-isoPGF 2a level was reported in dementia patients compared with controls 19 , while others demonstrated that there was no difference between dementia patients and healthy controls 20, 21 . Inconsistent with the results mentioned above, our study showed a significantly decrease in the level of urinary 8-isoPGF 2a in VaD patients compared to healthy subjects. Methodological differences and the autooxidation of samples in the process of preparation could explain these conflicting results. Furthermore, multiple physiological and pathological processes influence the concentration of isoprostanes in urine (e.g. lifestyle, diet, physical activity, smoker or non-smoker, cardiovascular diseases, diabetes). There was evidence indicating that 8-isoPGF 2a level in the body was closely linked to cigarette smoking and hypercholesterolemia 22 . However, subjects with cigarette smoking history were not excluded in our study. Accordingly, the urinary 8-isoPGF 2a levels might not accurately reflect lipid peroxidation and it was necessary to control for confounding results when analysing. Nitric oxide (NO) may react with superoxide radical anions giving peroxynitrite (ONOO-). Peroxynitrite acts on the protein molecule in the tyrosine residue, and its product NT could reduce the activity of enzymes in vivo, and prevent the activation of protein kinases. Previous studies suggested that the formation of NT was associated with a high degree of brain injury 23, 24 . However, one study did not find any difference in protein carbonyls between a small sample of stroke patients and controls 25 . Similarly to this study, we have found no difference in urinary NT among the three groups. Cigarette smoking has been shown to accelerate the nitrotyrosine-mediated oxidation 26, 27 . Therefore, the value of these biomarkers when studying dementia is strictly linked to the possibility of taking into account potential confounders (e.g. diet, smoking, comorbidity). One of the limitations of our study is that we did not exclude the subjects with cigarette smoking. In addition, the sample size in the present study was relatively small.
In conclusion, urinary 8-OHdG level was significantly higher while 8-isoPGF 2a level was lower in VaD patients in comparison to VaND patients and healthy controls. No statistically significant differences were detected in urinary NT levels among the three groups. This suggests that, even if the role of biochemical-markers in VaD has not yet been well-defined, urinary 8-OHdG levels are a potential marker of oxidative stress in VaD patients. A further step understanding urinary biomarkers in VaD patients compared to AD patients should be made in the future. Moreover, it is important to consider more than one biomarker in order to improve the identification of changes in the status of oxidative stress. The balance between antioxidants and by-products of oxidative stress in the body might be the best approach for the evaluation of oxidative stress in dementia patients 28 . Further studies are needed.
